GaPP: comparing gabapentin and placebo for Pelvic Pai
- Conditions
- Chronic pelvic painTherapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]MedDRA version: 20.0 Level: LLT Classification code 10048581 Term: Pelvic pain female System Organ Class: 100000004872
- Registration Number
- EUCTR2011-005494-22-GB
- Lead Sponsor
- niversity of Edinburgh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- 47
l Women aged between 1850
2 Pelvic pain of > 6 months
3 Pain located within the true pelvis or between and below anterior iliac crests, associated functional disability
4 No obvious pelvic pathology at laparoscopy (<6 months and >2 weeks ago)
5 Using effective contraception
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 60
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
l Known pelvic pathology eg endometriosis, cyst
2 Taking gabapentin or pregabalin or any restricted medications
3 Due to undergo surgery in the next 6 months
4 History of renal impairment
5 Allergic to gabapentin
6 Breast feeding
7 Pregnant or planning pregnancy in the next 6 months
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method